IL-10 and antibodies to TGF-β2 and PDGF inhibit RPE-mediated retinal contraction

Louise Carrington, David McLeod, Mike Boulton

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

PURPOSE. Retinal pigment epithelial (RPE) cells are believed to play a pivotal role in the formation and contraction of epiretinal membranes in proliferative vitreoretinopathy (PVR). In the present study, an organ culture method was used that mimics the contractile stage of PVR, to investigate the contribution of a variety of growth factors in human RPE cell-mediated contraction of the retina. METHODS. Cultured human RPE cells were seeded onto bovine retinal explants. After attachment, cultures received one of the following exogenous growth factors: platelet-derived growth factor (PDGF)-AB, PDGF-BB, basic fibroblast growth factor (bFGF), transforming growth factor (TGF)-β1, TGF-β2, or interleukin (IL)-10; or a neutralizing antibody to PDGF and/or TGF-β2. Control explants were either untreated or received a null antibody. Contraction was assessed by image analysis and expressed as percentage reduction in retinal area. RESULTS. RPE cells produced a more than 50% contraction of the retina after 7 days in untreated samples. PDGF and TGF-β2 stimulated RPE-mediated contraction by a further 20% at 100 ng/ml. IL-10 decreased contraction by 63%, whereas the other growth factors gave rise to similar contraction to untreated controls. Neutralizing antibodies against PDGF and TGF-β2 reduced RPE-mediated contraction by up to 70% in comparison with untreated controls. The neutralizing antibodies also inhibited the effects of exogenous PDGF and TGF-β2 on RPE-mediated contraction of the retina (P <0.01). CONCLUSIONS. These findings confirm a role for both PDGF and TGF-β2 in RPE cell-mediated contraction of the retina. Such contraction can be inhibited by neutralizing antibodies against PDGF and TGF-β2, which, together with IL-10, are putative candidates for therapeutic intervention in PVR.

Original languageEnglish (US)
Pages (from-to)1210-1216
Number of pages7
JournalInvestigative Ophthalmology and Visual Science
Volume41
Issue number5
StatePublished - 2000
Externally publishedYes

Fingerprint

Retinal Pigments
Platelet-Derived Growth Factor
Transforming Growth Factors
Interleukin-10
Antibodies
Proliferative Vitreoretinopathy
Neutralizing Antibodies
Epithelial Cells
Retina
Intercellular Signaling Peptides and Proteins
Epiretinal Membrane
Organ Culture Techniques
Fibroblast Growth Factor 2

ASJC Scopus subject areas

  • Ophthalmology

Cite this

IL-10 and antibodies to TGF-β2 and PDGF inhibit RPE-mediated retinal contraction. / Carrington, Louise; McLeod, David; Boulton, Mike.

In: Investigative Ophthalmology and Visual Science, Vol. 41, No. 5, 2000, p. 1210-1216.

Research output: Contribution to journalArticle

Carrington, Louise ; McLeod, David ; Boulton, Mike. / IL-10 and antibodies to TGF-β2 and PDGF inhibit RPE-mediated retinal contraction. In: Investigative Ophthalmology and Visual Science. 2000 ; Vol. 41, No. 5. pp. 1210-1216.
@article{05ec3f52829a4086af398ceac95fcd46,
title = "IL-10 and antibodies to TGF-β2 and PDGF inhibit RPE-mediated retinal contraction",
abstract = "PURPOSE. Retinal pigment epithelial (RPE) cells are believed to play a pivotal role in the formation and contraction of epiretinal membranes in proliferative vitreoretinopathy (PVR). In the present study, an organ culture method was used that mimics the contractile stage of PVR, to investigate the contribution of a variety of growth factors in human RPE cell-mediated contraction of the retina. METHODS. Cultured human RPE cells were seeded onto bovine retinal explants. After attachment, cultures received one of the following exogenous growth factors: platelet-derived growth factor (PDGF)-AB, PDGF-BB, basic fibroblast growth factor (bFGF), transforming growth factor (TGF)-β1, TGF-β2, or interleukin (IL)-10; or a neutralizing antibody to PDGF and/or TGF-β2. Control explants were either untreated or received a null antibody. Contraction was assessed by image analysis and expressed as percentage reduction in retinal area. RESULTS. RPE cells produced a more than 50{\%} contraction of the retina after 7 days in untreated samples. PDGF and TGF-β2 stimulated RPE-mediated contraction by a further 20{\%} at 100 ng/ml. IL-10 decreased contraction by 63{\%}, whereas the other growth factors gave rise to similar contraction to untreated controls. Neutralizing antibodies against PDGF and TGF-β2 reduced RPE-mediated contraction by up to 70{\%} in comparison with untreated controls. The neutralizing antibodies also inhibited the effects of exogenous PDGF and TGF-β2 on RPE-mediated contraction of the retina (P <0.01). CONCLUSIONS. These findings confirm a role for both PDGF and TGF-β2 in RPE cell-mediated contraction of the retina. Such contraction can be inhibited by neutralizing antibodies against PDGF and TGF-β2, which, together with IL-10, are putative candidates for therapeutic intervention in PVR.",
author = "Louise Carrington and David McLeod and Mike Boulton",
year = "2000",
language = "English (US)",
volume = "41",
pages = "1210--1216",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "5",

}

TY - JOUR

T1 - IL-10 and antibodies to TGF-β2 and PDGF inhibit RPE-mediated retinal contraction

AU - Carrington, Louise

AU - McLeod, David

AU - Boulton, Mike

PY - 2000

Y1 - 2000

N2 - PURPOSE. Retinal pigment epithelial (RPE) cells are believed to play a pivotal role in the formation and contraction of epiretinal membranes in proliferative vitreoretinopathy (PVR). In the present study, an organ culture method was used that mimics the contractile stage of PVR, to investigate the contribution of a variety of growth factors in human RPE cell-mediated contraction of the retina. METHODS. Cultured human RPE cells were seeded onto bovine retinal explants. After attachment, cultures received one of the following exogenous growth factors: platelet-derived growth factor (PDGF)-AB, PDGF-BB, basic fibroblast growth factor (bFGF), transforming growth factor (TGF)-β1, TGF-β2, or interleukin (IL)-10; or a neutralizing antibody to PDGF and/or TGF-β2. Control explants were either untreated or received a null antibody. Contraction was assessed by image analysis and expressed as percentage reduction in retinal area. RESULTS. RPE cells produced a more than 50% contraction of the retina after 7 days in untreated samples. PDGF and TGF-β2 stimulated RPE-mediated contraction by a further 20% at 100 ng/ml. IL-10 decreased contraction by 63%, whereas the other growth factors gave rise to similar contraction to untreated controls. Neutralizing antibodies against PDGF and TGF-β2 reduced RPE-mediated contraction by up to 70% in comparison with untreated controls. The neutralizing antibodies also inhibited the effects of exogenous PDGF and TGF-β2 on RPE-mediated contraction of the retina (P <0.01). CONCLUSIONS. These findings confirm a role for both PDGF and TGF-β2 in RPE cell-mediated contraction of the retina. Such contraction can be inhibited by neutralizing antibodies against PDGF and TGF-β2, which, together with IL-10, are putative candidates for therapeutic intervention in PVR.

AB - PURPOSE. Retinal pigment epithelial (RPE) cells are believed to play a pivotal role in the formation and contraction of epiretinal membranes in proliferative vitreoretinopathy (PVR). In the present study, an organ culture method was used that mimics the contractile stage of PVR, to investigate the contribution of a variety of growth factors in human RPE cell-mediated contraction of the retina. METHODS. Cultured human RPE cells were seeded onto bovine retinal explants. After attachment, cultures received one of the following exogenous growth factors: platelet-derived growth factor (PDGF)-AB, PDGF-BB, basic fibroblast growth factor (bFGF), transforming growth factor (TGF)-β1, TGF-β2, or interleukin (IL)-10; or a neutralizing antibody to PDGF and/or TGF-β2. Control explants were either untreated or received a null antibody. Contraction was assessed by image analysis and expressed as percentage reduction in retinal area. RESULTS. RPE cells produced a more than 50% contraction of the retina after 7 days in untreated samples. PDGF and TGF-β2 stimulated RPE-mediated contraction by a further 20% at 100 ng/ml. IL-10 decreased contraction by 63%, whereas the other growth factors gave rise to similar contraction to untreated controls. Neutralizing antibodies against PDGF and TGF-β2 reduced RPE-mediated contraction by up to 70% in comparison with untreated controls. The neutralizing antibodies also inhibited the effects of exogenous PDGF and TGF-β2 on RPE-mediated contraction of the retina (P <0.01). CONCLUSIONS. These findings confirm a role for both PDGF and TGF-β2 in RPE cell-mediated contraction of the retina. Such contraction can be inhibited by neutralizing antibodies against PDGF and TGF-β2, which, together with IL-10, are putative candidates for therapeutic intervention in PVR.

UR - http://www.scopus.com/inward/record.url?scp=0034069958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034069958&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 1210

EP - 1216

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 5

ER -